CCTA-quantified pericornary inflammation and lipoprotein (a): Combined predictive value in non-obstructive CAD

IF 3.2 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Xueqiao Yang , Bowen Li , Huiyu Chen , Ruyue Ding , Na Chang , Congshan Ji , Hui Gu , Ximing Wang
{"title":"CCTA-quantified pericornary inflammation and lipoprotein (a): Combined predictive value in non-obstructive CAD","authors":"Xueqiao Yang ,&nbsp;Bowen Li ,&nbsp;Huiyu Chen ,&nbsp;Ruyue Ding ,&nbsp;Na Chang ,&nbsp;Congshan Ji ,&nbsp;Hui Gu ,&nbsp;Ximing Wang","doi":"10.1016/j.ijcard.2025.133887","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to enhance major adverse cardiovascular events (MACEs) prediction by pericoronary adipose tissue attenuation (PCATa) in non-obstructive coronary artery disease (CAD) patients when combined with lipoprotein (a) (Lp(a)).</div></div><div><h3>Methods</h3><div>A total of 1052 patients with non-obstructive CAD were included. Detailed clinical data and CCTA features were analyzed. The MACEs in this study was defined as a composite of non-fatal myocardial infarction, new-onset heart failure requiring hospitalization, stroke, all-cause mortality, and coronary revascularization.</div></div><div><h3>Results</h3><div>During a median follow-up of 6.8 (5.6–7.9) years, 183 (17.4 %) patients suffered from MACEs. Patients experiencing MACEs demonstrated elevated Lp(a) levels and PCATa values (26.20 (17.63–45.08) vs. 12.00 (4.58–26.00), <em>P</em> &lt; 0.001; −72.6 ± 8.4 HU vs. -79.7 ± 9.5 HU, <em>P</em> &lt; 0.001). Lp(a) was associated with PCATa (<em>P</em> &lt; 0.001). Elevated PCATa was associated with quantitatively greater atherosclerotic burden (<em>P</em> &lt; 0.001). Multivariate Cox regression showed that age (HR = 1.03, <em>P</em> = 0.001), hypertension (HR = 1.39, <em>P</em> = 0.036), triglyceride (HR = 1.23, <em>P</em> = 0.003), high-risk plaque (HR = 2.30, <em>P</em> &lt; 0.001), LAPV% (HR = 2.66, <em>P</em> &lt; 0.001), Lp(a) (HR = 1.26, <em>P</em> &lt; 0.001) and PCATa (HR = 1.44, <em>P</em> &lt; 0.001) were independently associated with increased risk of MACEs. Kaplan-Meier analysis demonstrated that patients with Lp(a) ≥30 mg/dL and PCATa &gt; − 78 HU had the highest incidence of MACEs (<em>P</em> &lt; 0.001). Additionally, combination Lp(a) and PCATa showed the highest AUC (<em>P</em> &lt; 0.001).</div></div><div><h3>Conclusion</h3><div>Incorporating Lp(a) and PCATa significantly improves MACEs prediction in non-obstructive CAD patients, where higher Lp(a) levels are linked to elevated PCATa.</div></div>","PeriodicalId":13710,"journal":{"name":"International journal of cardiology","volume":"442 ","pages":"Article 133887"},"PeriodicalIF":3.2000,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167527325009301","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

This study aimed to enhance major adverse cardiovascular events (MACEs) prediction by pericoronary adipose tissue attenuation (PCATa) in non-obstructive coronary artery disease (CAD) patients when combined with lipoprotein (a) (Lp(a)).

Methods

A total of 1052 patients with non-obstructive CAD were included. Detailed clinical data and CCTA features were analyzed. The MACEs in this study was defined as a composite of non-fatal myocardial infarction, new-onset heart failure requiring hospitalization, stroke, all-cause mortality, and coronary revascularization.

Results

During a median follow-up of 6.8 (5.6–7.9) years, 183 (17.4 %) patients suffered from MACEs. Patients experiencing MACEs demonstrated elevated Lp(a) levels and PCATa values (26.20 (17.63–45.08) vs. 12.00 (4.58–26.00), P < 0.001; −72.6 ± 8.4 HU vs. -79.7 ± 9.5 HU, P < 0.001). Lp(a) was associated with PCATa (P < 0.001). Elevated PCATa was associated with quantitatively greater atherosclerotic burden (P < 0.001). Multivariate Cox regression showed that age (HR = 1.03, P = 0.001), hypertension (HR = 1.39, P = 0.036), triglyceride (HR = 1.23, P = 0.003), high-risk plaque (HR = 2.30, P < 0.001), LAPV% (HR = 2.66, P < 0.001), Lp(a) (HR = 1.26, P < 0.001) and PCATa (HR = 1.44, P < 0.001) were independently associated with increased risk of MACEs. Kaplan-Meier analysis demonstrated that patients with Lp(a) ≥30 mg/dL and PCATa > − 78 HU had the highest incidence of MACEs (P < 0.001). Additionally, combination Lp(a) and PCATa showed the highest AUC (P < 0.001).

Conclusion

Incorporating Lp(a) and PCATa significantly improves MACEs prediction in non-obstructive CAD patients, where higher Lp(a) levels are linked to elevated PCATa.

Abstract Image

ccta量化的冠状动脉周围炎症和脂蛋白(a):非阻塞性CAD的联合预测价值。
目的:本研究旨在通过冠状动脉周围脂肪组织衰减(PCATa)联合脂蛋白(Lp(a))增强对非阻塞性冠状动脉疾病(CAD)患者主要不良心血管事件(mace)的预测。方法:共纳入1052例非阻塞性CAD患者。详细分析临床资料及CCTA特征。本研究中的mace定义为非致死性心肌梗死、需要住院治疗的新发心力衰竭、中风、全因死亡率和冠状动脉血运重建术的组合。结果:在中位随访6.8(5.6-7.9)年期间,183例(17.4 %)患者发生mace。经历mace的患者表现出Lp(a)水平和PCATa值升高(26.20 (17.63-45.08)vs. 12.00 (4.58-26.00), P  - 78 HU的mace发生率最高(P )结论:合并Lp(a)和PCATa可显著改善非阻塞性CAD患者的mace预测,其中较高的Lp(a)水平与PCATa升高有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International journal of cardiology
International journal of cardiology 医学-心血管系统
CiteScore
6.80
自引率
5.70%
发文量
758
审稿时长
44 days
期刊介绍: The International Journal of Cardiology is devoted to cardiology in the broadest sense. Both basic research and clinical papers can be submitted. The journal serves the interest of both practicing clinicians and researchers. In addition to original papers, we are launching a range of new manuscript types, including Consensus and Position Papers, Systematic Reviews, Meta-analyses, and Short communications. Case reports are no longer acceptable. Controversial techniques, issues on health policy and social medicine are discussed and serve as useful tools for encouraging debate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信